Document:

Exhibit

Exhibit 4.2

DESCRIPTION OF CAPITAL STOCK

The following is a brief description of the capital stock of Cerner Corporation, a Delaware corporation (the “Company,” “we,” “us,” or “our”). The brief description is based on our Third Restated Certificate of Incorporation (our “charter”), amended and restated bylaws (our “bylaws”), and provisions of applicable law. The following description does not purport to be complete and is subject to, and qualified in its entirety by, the full text of our charter and our bylaws, which we have previously filed with the SEC and are incorporated by reference herein.

GENERAL

The Company’s authorized capital stock consists of 500,000,000 shares of common stock, par value $0.01 per share, and 1,000,000 shares of preferred stock, par value $0.01 per share. As of December 28, 2019, an aggregate of 367,634,796 shares of common stock were issued, of which an aggregate of 310,911,250 shares were outstanding. No shares of preferred stock were issued and outstanding as of December 28, 2019.

COMMON STOCK

Voting Rights
 
The holders of our common stock are entitled to one vote per share on any matter to be voted upon by stockholders. The holders of a majority of the outstanding shares of stock entitled to vote at a meeting, present in person or represented by proxy, constitute a quorum at all stockholder meetings for the transaction of business, except as otherwise provided by law, our charter or our bylaws.  Every decision of a majority in amount of stock of such quorum will be valid as a corporate act, except in the election of directors or in those specific instances in which a larger vote is required by law or by our charter or our bylaws.  The holders of common stock are not entitled to cumulative voting rights with respect to the election of directors.  Stockholders elect directors by the affirmative vote of a majority of the votes cast, in person or by proxy, by the holders of outstanding shares of stock entitled to vote for the election of directors; provided that if the number of nominees exceeds the number of directors to be elected at any time before the election, the stockholders will instead elect the directors by a plurality vote.
 
Dividends
 
The holders of our common stock are entitled to such dividends as our Board of Directors may declare from time to time from legally available funds, subject to limitations under Delaware law and the preferential rights of the holders of any outstanding shares of preferred stock.
 
Liquidation
 
Upon any voluntary or involuntary liquidation, dissolution or winding up of our affairs, the holders of our common stock shall be entitled to receive, ratably in proportion to the number of shares of common stock held by them respectively, all of the remaining 

assets of the Company after payment to creditors and subject to prior distribution rights granted to the holders of any outstanding shares of preferred stock.

No Preemptive or Similar Rights

Our common stock is not entitled to preemptive rights, conversion or other rights to subscribe for additional securities and there are no redemption or sinking fund provisions applicable to our common stock.

Fully Paid and Non-assessable

All of the outstanding shares of common stock are fully paid and non-assessable.

PREFERRED STOCK

Our Board of Directors is authorized, without any further action by our stockholders, but subject to the limitations imposed by the General Corporation Law of Delaware (the “DGCL”), to issue up to 1,000,000 shares of preferred stock in one or more series. Our Board of Directors may fix the rights, preferences and privileges of the preferred stock, along with any limitations or restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences of each series of preferred stock. The preferred stock could have voting or conversion rights that could adversely affect the voting power or other rights of holders of our common stock. Also, the issuance of preferred stock could decrease the amount of earnings and assets available for distribution to holders of our common stock.

CERTAIN EFFECTS OF AUTHORIZED BUT UNISSUED STOCK

We may issue additional shares of common stock or preferred stock without stockholder approval, subject to applicable rules of the The Nasdaq Stock Market LLC and Delaware law, for a variety of corporate purposes, including future public or private offerings to raise capital, corporate acquisitions, and employee benefit plans and equity grants. The existence of unissued and unreserved common stock and preferred stock may enable us to issue shares to persons who are friendly to current management, which could discourage an attempt to obtain control of the Company by means of a proxy contest, tender offer, merger, or otherwise.

ANTI-TAKEOVER EFFECTS OF PROVISIONS OF OUR CHARTER AND BYLAWS

The following is a brief description of the provisions in our charter and bylaws that could have an effect of delaying, deferring, or preventing a change in control of the Company.

Classified Board

Our charter and bylaws provide that the number of the Board of Directors shall be divided into three classes. Stockholders elect the directors of each class for three-year terms upon the expiration of the current term of a respective class. Stockholders elect only one class of directors each year. The classified Board of Directors could have the effect of making the replacement of 

the Company’s incumbent directors more time consuming and difficult. At least two annual meetings of stockholders are generally required to effect a change in a majority of our Board of Directors. 

Director Vacancies and Removal

Our charter and bylaws provide that any vacancies on our Board of Directors and newly created directorships will be filled by the affirmative vote of a majority of the remaining directors, although less than a quorum, or by a sole remaining director.  Our charter and bylaws provide that directors may be removed only for cause and only by the affirmative vote of the holders of 80% or more of the aggregate of all votes of all outstanding shares of capital stock entitled to vote on such removal. 
 
Advance Notice for Stockholder Proposals and Nominations

Our bylaws contain provisions requiring advance notice be delivered to the Company of any business to be brought by a stockholder before an annual meeting and providing for procedures to be followed by stockholders in nominating persons for election to our Board of Directors, including stockholder nominees to be included in our proxy statement. A stockholder must give notice no later than the 90th day nor earlier than the 120th days before the one-year anniversary of the date on which we held our annual meeting of stockholders the previous year. The notice must contain the information required by our bylaws, and the stockholder(s) and nominee(s) must comply with the information and other requirements required by our bylaws. 

Limits on Ability of Stockholders to Call a Special Meeting or Act by Written Consent

Our charter and bylaws provide that special meetings of the stockholders may be called only by the chairman of the Board of Directors, by the chief executive officer, by the president or by the Board of Directors pursuant to a resolution approved by a majority of the entire Board of Directors. Our charter and bylaws also eliminate the ability of stockholders to take action by written consent.  These provisions may delay the ability of our stockholders to force consideration of a proposal. 

No Cumulative Voting
 
The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless our charter provides otherwise. Our charter does not provide for cumulative voting for our directors. The absence of cumulative voting may make it more difficult for stockholders owning less than a majority of our common stock to elect any directors to our Board of Directors.

Approval of Business Combinations with Interested Stockholders

Our charter requires the affirmative vote of 80% or more of the aggregate of all votes of all outstanding shares of capital stock entitled to vote on the issue to approve certain transactions with any stockholder owning 5% or more of our outstanding shares of capital stock at the time of approval of the transactions (including any affiliates of such stockholder, an “Interested Stockholder”). The covered transactions include a merger or consolidation with an Interested Stockholder, any sale, lease, exchange or other disposition to an Interested Stockholder of our assets having an aggregate Fair Market Value (as defined in the charter) of $500,000 or more, the issuance or transfer of securities to an Interested Stockholder in exchange for cash, securities or other property having 

a Fair Market Value (as defined in the charter) of $500,000 or more, the adoption of any plan or proposal for liquidation or dissolution proposed by an Interested Stockholder, or any reclassification of securities that increases the voting power of the Interested Stockholder. The foregoing 80% stockholder approval requirement is not required in certain circumstances, including if the transaction has been approved by a majority of Disinterested Directors (as defined in our charter).

Supermajority Voting Requirements to Amend Our Charter and Bylaws

Our charter includes a number of supermajority voting provisions that could make it more difficult to change certain of the provisions described above.  These provisions require the affirmative vote of 80% or more of the aggregate of all votes of all outstanding shares of capital stock entitled to vote on the issue in question to amend, alter repeal (or adopt, amend or alter provisions in conflict with) the provisions of our charter relating to the terms of our capital stock, the election and removal of directors, changes to our classified board structure, approval of business combinations with an Interested Stockholder, the right of stockholders to act by written consent or the ability of stockholders to call a special meeting.  Our charter also provides that our bylaws may only be adopted, amended, altered or repealed by our board or by the affirmative vote of 80% or more of the aggregate of all votes of all outstanding shares of capital stock entitled to vote thereon. 

LISTING

Our common stock is traded on the Nasdaq Global Select Market under the symbol “CERN.”

TRANSFER AGENT AND REGISTRAR

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.Exhibit

Exhibit 10.7
SEPARATION AGREEMENT
This Separation Agreement (“Separation Agreement”), is made by and between Cerner Corporation (together with its subsidiaries and affiliates, “Cerner”) and Michael R. Nill (“you” or “your” and, together with Cerner, the “parties”).  
RECITALS
WHEREAS, you are currently, and have been since May 15, 2011, the Executive Vice President and Chief Operating Officer of Cerner and have been employed by Cerner since November 18, 1996; 
WHEREAS, you entered into a Cerner Associate Employment Agreement with Cerner dated November 18, 1996 (your “EA”), as amended by the Cerner Executive Severance Agreement dated September 11, 2017 (your “Severance Agreement” and together with your EA, your “Employment Agreement”), and a Mutual Arbitration Agreement with Cerner dated December 1, 2015 (your “Arbitration Agreement”);
WHEREAS, you are departing from Cerner, and the parties have mutually agreed to the separation benefits described herein;
WHEREAS, your last day of employment for salary, cash awards under the Cerner Corporation 2018 Performance Compensation Plan (“CPP”), benefits, regular equity vesting and transition purposes will be January 10, 2020; and
WHEREAS, in consideration for the separation payments and acceleration of the vesting of outstanding equity-based compensation awards described herein, and other good and valuable consideration, the receipt and sufficiency of which you and Cerner hereby acknowledge, you agree to the terms contained herein and, as described below, agree to release Cerner and the Cerner Released Parties (as defined in this Separation Agreement) from matters arising out of or related to your employment with Cerner.
NOW, THEREFORE, in consideration of the mutual covenants, promises, and obligations set forth herein, the parties agree as follows:  
		
	1.
	SEPARATION BENEFITS. Subject to your acceptance and timely return of this Separation Agreement to Cerner, without revocation, Cerner agrees to the following:  

		
	A.
	Your last day of employment for salary, CPP, benefits, reimbursement of expenses, regular equity vesting and transition purposes will be January 10, 2020, and Cerner will continue to pay your salary through January 10, 2020, on Cerner’s regular paydays. As of January 10, 2020, you shall cease to be covered by Cerner’s insider trading policy and shall cease to be covered by Cerner’s stock ownership guidelines and you shall be free to trade any shares of Cerner stock that you own, subject to your compliance with insider trading and short-swing profit rules. 

		
	B.
	Cerner will provide you with separation payments of $62,208.49, less applicable deductions required by law, on a biweekly basis on Cerner’s regular paydays during the twenty-four (24) month period following January 10, 2020, commencing on the January 24, 2020 payday. Such biweekly separation payments are based upon (i) your annual base salary effective March 31, 

2019 ($690,000); (ii) your annual target cash bonus effective March 31, 2019 ($911,000); plus (iii) the difference between the monthly COBRA continuation premium for you and your partner, spouse or dependents under Cerner's health, vision and dental plans in effect as of the date of your termination and the monthly amount you were paying for such coverage.  

		
	C.
	As of the Effective Date of this Separation Agreement, Cerner will, with respect to each of your outstanding equity awards as of the date hereof and granted by Cerner to you pursuant to an equity compensation plan approved by Cerner's shareholders and relating to Cerner common stock (each a “Cerner Equity Award”) (i) fully vest each Cerner Equity Award that is an outstanding unvested stock option (and you shall have the earlier of one year from the Effective Date and the balance of the original option term to exercise such option); (ii) fully vest each Cerner Equity Award that is an outstanding unvested time-based Restricted Stock Unit (“RSU”); and (iii) fully vest each Cerner Equity Award that is an outstanding unvested Performance Share Unit (“PSU”), including the RSUs and PSUs granted to you on April 29, 2019, assuming a 100% of target level of achievement. Each of the grant instruments for any Cerner Equity Award the vesting or exercise of which is adjusted by this Paragraph 1.C. is hereby deemed amended by the parties upon the Effective Date of this Separation Agreement.

		
	2.
	In the event of your death before the completion of the payout of any of the benefits described in Paragraph 1, Cerner will pay the remaining benefits described in Paragraph 1 in a lump sum to your designated Beneficiary separately communicated to Cerner provided that Beneficiary completes and delivers a Form W-9 to Cerner. You may revoke or change this Beneficiary designation at any time by delivering to Cerner a written document signed by you with the attestation of a notary stating that you are revoking or changing the designation, provided that such document is delivered while you are still alive and of sound mind. If your designated Beneficiary does not survive you or if your deaths are simultaneous, this paragraph and designation shall be void and of no effect, and any payments due under Paragraph 1 shall be made to your estate. 

		
	3.
	YOUR RELEASE OF CLAIMS. On behalf of yourself and your successors, assigns, agents, heirs and descendants, you hereby acquit, release and forever discharge Cerner and its affiliates and subsidiaries, and all of their successors, assigns, officers, directors, agents, servants, employees, shareholders, fiduciaries, attorneys and representatives, whether past or present for all of the foregoing (collectively, the “Cerner Released Parties”) from any and all manner of claims, debts, damages, injuries, judgments, awards, executions, demands, liabilities, obligations, suits, actions and causes of action, whether known or unknown, fixed or contingent, accrued or to accrue, direct or indirect, and whether at law or in equity, which you may have against the Cerner Released Parties, including, but not limited to, those arising out of or by reason of your employment by Cerner, or with respect to your departure from employment with Cerner and/or its subsidiaries, or with respect to claims for expenses, salary, incentive payments or equity grants against Cerner.  

Without in any way limiting the generality of the foregoing, you acknowledge and agree that you are hereby releasing and discharging Cerner and all other Cerner Released Parties from any and all manner of claims, debts, damages, injuries, judgments, awards, executions, demands, liabilities, obligations, suits, actions and causes of action that may be asserted under any local, state, federal, statutory or common law relating to discrimination in employment including, without limitation, discrimination relating to race, ethnicity, religion, sex, pregnancy, disability, equal pay, age, veteran status, national origin, creed, color, and retaliation, and including claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans with Disabilities Act, the Equal Pay Act, the Age Discrimination in Employment Act, Family and Medical Leave Act, 42 U.S.C. Sections 1981, 1983 

and 1985, the Employee Retirement Income Security Act (“ERISA”), Workmen’s Compensation laws, Consolidated Omnibus Budget Reconciliation Act, the Worker Adjustment and Retraining Notification Act, Executive Order 11246, the Rehabilitation Act, veterans’ laws, all federal, state and local laws related to libel, slander, defamation, invasion of privacy, breach of contract, outrageous conduct, intentional or negligent infliction of emotional distress, respondent superior, negligent hiring or retention, and all other laws and ordinances which are meant to protect workers in their employment relationships and under which you might have rights and claims. 
		
	A.
	Includes Release of ADEA Claims. You understand and agree that you are releasing Cerner and all other Cerner Released Parties from all rights and claims of discrimination relating to age, including all rights and claims under the Age Discrimination in Employment Act of 1967, as amended (hereinafter referred to as “ADEA”).  

		
	B.
	Nothing in this Separation Agreement is intended to, or shall, interfere with your rights under federal, state, or local civil rights or employment discrimination laws to file or otherwise institute a charge of discrimination, to participate in a proceeding with any appropriate federal, state, or local government agency enforcing discrimination laws, or to cooperate with any such agency in its investigation, none of which shall constitute a breach of this letter agreement. You shall not, however, be entitled to any relief, recovery, or monies in connection with any such action or investigation brought against Cerner, regardless of who filed or initiated any such complaint, charge, or proceeding. Nothing in this Separation Agreement is intended to, or shall, interfere with your right to file a claim for unemployment benefits (if any), or to file a claim asserting any causes of action which by law you may not legally waive.

		
	C.
	Nothing in this Separation Agreement is intended to, or shall, interfere with (1) your rights to indemnification under Cerner’s bylaws (and Cerner agrees to keep in force sufficient directors and officers insurance to protect you against such potential liabilities for a period of three years from the Effective Date). (2) your rights to vested ERISA benefits; and (3) your rights under this Separation Agreement.  

		
	4.
	CERNER’S RELEASE OF CLAIMS. Cerner, its affiliates and subsidiaries and all of their successors and assigns (collectively, the “Cerner Parties”) hereby acquit, release and forever discharge you and your successors, assigns, agents, heirs and descendants, from any and all manner of claims, debts, damages, injuries, judgments, awards, executions, demands, liabilities, obligations, suits, actions and causes of action that have accrued as of and are known to Cerner on your termination date, whether direct or indirect and whether at law or in equity, which the Cerner Parties may have against you arising out of your employment with Cerner. The Cerner Parties’ release of claims does apply to any and all employment claims brought by Cerner associates or third parties, whether known or unknown to Cerner on your termination date. The Cerner Parties’ release of claims does not apply to claims related to the enforcement of or your failure to comply with this Agreement or your violation of your noncompetition, confidentiality, and non-solicitation obligations.

		
	5.
	RETURN OF CERNER PROPERTY. You acknowledge that you will return all Cerner-issued equipment, including, but not limited to, your security card/office key to the building(s) upon your January 10, 2020 termination date. Cerner agrees you will not be required to return your laptop, ipad and cell phone and you may retain those devices as personal property after your January 10, 2020 termination date; however, you agree that you will first work with Cerner to ensure that corporate data is appropriately transferred to Cerner information systems and wiped from the devices and to allow Cerner to preserve potentially relevant data for any pending legal matters. You further 

acknowledge and agree that you will return all other Cerner property, manuals or other intellectual property, confidential information or materials containing trade secrets of Cerner in your possession and that no copies thereof will be retained by you or on your behalf by any third party after your January 10, 2020 termination date. 

		
	6.
	OBLIGATIONS WITH RESPECT TO CONFIDENTIALITY. You acknowledge and agree that all confidentiality obligations and covenants set forth in your Employment Agreement or any other employment agreement that you signed at the time of or during your employment by Cerner or any of its subsidiaries shall continue in full force and effect.  

Nothing in this Separation Agreement shall (i) prohibit you from disclosing confidential information in connection with reporting possible violations of law or regulation to any governmental agency or entity or attorney in accordance with any whistleblower protection provisions of applicable law or regulation, including 18 USC 1833, or (ii) require notification or prior approval by Cerner of any reporting described in clause (i); provided, however, that any such disclosures must be made in accordance with the applicable law or regulation and in a manner that limits, to the furthest extent possible, disclosure of confidential information.
		
	7.
	NON-SOLICITATION. In consideration for the separation payments to be provided under this Separation Agreement, you agree, subject to applicable state law, that for a period of two (2) years following the termination of your employment, you will not, directly or indirectly, on behalf of yourself or on behalf of any other person, entity, or organization, solicit for employment (i) any Cerner associate, or (ii) any employee of a Cerner client company with whom you have had personal interaction within the one year prior to your separation date. For purposes of this Paragraph 7, “solicit” means that you will not affirmatively initiate communications with (i) any Cerner associate, or (ii)any employee of a Cerner client company with whom you have had personal interaction within the one year prior to your separation date, for the purpose of inviting such associate or employee to apply for or consider employment with another person, entity, or organization.  For the avoidance of doubt, this provision shall in no way prohibit job postings of general applicability, provided that they are not specifically targeted at (i) employees of Cerner, or (ii) employees of a Cerner client company with whom you have had personal interaction within the one year prior to your separation date (or from hiring an individual via such a job posting).  You further agree that the obligations set forth herein are in lieu of the non-solicit obligation in your Employment Agreement 

		
	8.
	COOPERATION. You agree that you will cooperate with Cerner in a professional manner in the transition of your job duties, and in the defense of any legal matters about which you have material knowledge. 

		
	9.
	CONSIDERATION PERIOD. You acknowledge that you have twenty-one (21) days from the date you received this Separation Agreement in which to consider it, although you may sign this Separation Agreement earlier than 21 days if you so choose. You further understand that you have the right to revoke this Separation Agreement by delivering written notice to Cerner during the seven-day period after you sign it. This Separation Agreement shall become effective after the seven-day revocation period has expired assuming you do not revoke it, but in no event earlier than January 18, 2020 (the “Effective Date”).

		
	10.
	NO FURTHER PAYMENTS. You agree that your employment will terminate effective January 10, 2020, and that, after that date, Cerner will owe no additional compensation to you other than: (i) your final paycheck covering the period through January 10, 2020, (ii) any performance-based cash 

incentive compensation earned but not yet paid as of January 10, 2020 (including, the Q4 2019 CPP bonus as described in Paragraph 10.B., below), and (iii) the separation benefits described in Paragraph 1. 

		
	A.
	You agree that amounts paid pursuant to this Separation Agreement shall be in full and final satisfaction of any amounts or other benefits that could be owed to you under any other agreement you may have entered into with Cerner or, except as required by law or specifically provided herein, any other Cerner benefit plan or arrangement, including but not limited to your Employment Agreement (including Paragraph 8 of that Employment Agreement), the Enhanced Severance Pay Plan or the Business Optimization Severance Pay Plan. 

		
	B.
	You will remain eligible to participate in the Cerner Corporation 2018 Performance Compensation Plan (“CPP”) through the last day of the fourth fiscal quarter of 2019. Calculations and payments under the CPP for Q4 2019 shall be governed by the CPP and equal to the actual CPP metrics achieved or not achieved in that quarter. That amount will be paid to you in accordance with Cerner’s regular 2019 CPP payment schedule. You acknowledge that you are not eligible for and will not receive any further payments under the CPP after Q4 2019. 

		
	11.
	FORFEITURE AND REIMBURSEMENT. By signing this Separation Agreement, you agree that the promises you have made in it are of a special nature and that any material breach or material violation by you of the terms of this Separation Agreement will result in immediate and irreparable harm to Cerner. If you are found by a Court or Arbitrator to have committed a material breach of any confidentiality, non-competition, non-solicitation or other material provision in this Separation Agreement or your Employment Agreement, (i) Cerner’s obligation, if applicable, to deliver separation payments and benefits to you under this Separation Agreement will cease immediately, (ii) you will be obligated to reimburse Cerner for all separation payments already made to you under Paragraph 1.B., (iii) any outstanding Cerner Equity Award held by you will immediately be forfeited notwithstanding any contrary term or condition in any underlying grant instrument, and (iv) you will be obligated to return to Cerner all shares of Cerner common stock (or the proceeds from the sale of such shares if such shares have been sold) received by you under, or as a result of your exercise of, a Cerner Equity Award which was subject to accelerated vesting in accordance with Paragraph 1.C. Cerner will also be entitled to all other legal and equitable remedies available to it by law.

		
	12.
	NONADMISSION OF LIABILITY. You understand and agree that neither this Separation Agreement nor any action taken hereunder is to be construed as an admission of liability by Cerner or any of the Cerner Released Parties.

		
	13.
	VOLUNTARY EXECUTION. You acknowledge that you have read this Separation Agreement in its entirety, that you understand its contents, and that you have executed it voluntarily. You further acknowledge that you have consulted with your attorney prior to signing this Separation Agreement.

		
	14.
	COMPLIANCE WITH SECTION 409A.  Notwithstanding any other provision of this Separation Agreement, all payments provided hereunder shall be made in a manner that is intended to comply with Section 409A or an applicable exemption thereto, including the separation pay and short-term deferral exceptions. Any payment provided under this Separation Agreement which is required to be delayed for six months following your separation from service and on account of you being a “specified employee” of Cerner shall be so delayed. For purposes of Section 409A, each installment payment provided under this Separation Agreement shall be treated as a separate payment. Notwithstanding 

the foregoing, Cerner makes no representations that the payments and benefits provided under this Separation Agreement comply with Section 409A, and in no event shall Cerner be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by you on account of non-compliance with Section 409A. 

		
	15.
	NOTICE. All notices, requests, demands and other communications hereunder shall be deemed duly given if delivered by hand or if mailed by certified or registered mail or sent by express courier with postage or charges prepaid as follows:

If to Cerner:
Cerner Corporation
2800 Rockcreek Parkway
North Kansas City, MO  64117-2551
Attn: Chief Financial Officer 
With copy to:  General Counsel

If to you:    
At the address on file with Cerner’s HR department

With copy to:

Joseph S. Adams
Winston & Strawn
35 W. Wacker Drive
Chicago, IL  60601
        
or to any other address as either party may provide to the other in writing by notice given in accordance with this paragraph.
		
	16.
	NOTICE TO SUBSEQUENT EMPLOYER. You agree to inform any potential new employer, prior to accepting such employment, of the existence of the non-competition, non-solicitation and confidentiality provisions contained in this Separation Agreement and your Employment Agreement. 

		
	17.
	GOVERNING LAW. This Separation Agreement shall be governed by and construed in accordance with the laws of the State of Missouri to the extent not governed or preempted by federal law. 

		
	18.
	SEVERABILITY. If any provision of this Separation Agreement is held to be unenforceable, this Separation Agreement will be deemed amended to the extent necessary to render the otherwise unenforceable provision-and the rest of this Separation Agreement-valid and enforceable. If an arbitrator (or court) declines to amend this Separation Agreement as provided in this paragraph, the invalidity or unenforceability of any provision of this Separation Agreement will not affect the validity or enforceability of the remaining provisions, which must be enforced as if the offending provision had not been included in this Separation Agreement. 

		
	19.
	COMPLETE AGREEMENT. This Separation Agreement constitutes the full, complete and entire agreement of the parties related to the separation benefits to which you are entitled. Without limitation, 

the separation benefits and payments under this Separation Agreement supersede and replace any benefits or payments you might otherwise be eligible to receive under your Employment Agreement, the Cerner Enhanced Severance Pay Plan, any successor thereto, or any other broad-based Cerner severance plan or policy which otherwise would be applicable to you. However, the parties agree that your Employment Agreement (excluding any right you have to any severance payment or severance benefit thereunder), otherwise remains in full force and effect. For the avoidance of doubt, your Arbitration Agreement shall survive this Separation Agreement. In making this Separation Agreement, the parties rely wholly upon their own judgment, belief and knowledge and the advice of their respective counsel. All executed copies, whether signed in counterparts or otherwise, or duplicate originals, are equally admissible in evidence.

This Separation Agreement is executed as of this 10th day of January 2020.

	
	
	/s/ Michael R. Nill

	Michael R. Nill

	 

	 

	Cerner Corporation

	
		
	By:
	/s/ Tracy Platt

	 
	Tracy Platt

	 
	Executive Vice President and Chief

	 
	Human Resources Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]